Promising drug targets rare cancer that blocks blood vessels
NCT ID NCT07104331
First seen Feb 20, 2026 · Last updated May 23, 2026 · Updated 9 times
Summary
This study tests a drug called nab-sirolimus in 41 people with a rare cancer of the blood vessels (EHE) that is growing or causing symptoms. The drug is given through a vein twice every 3 weeks. The main goal is to see if it shrinks tumors. This is a phase 2 trial, meaning it's checking if the drug works well enough for further testing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPITHELIOID HEMANGIOENDOTHELIOMA (EHE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
NOT_YET_RECRUITINGBoston, Massachusetts, 02115, United States
-
Dana-Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Sloan Kettering Institute for Cancer Research
NOT_YET_RECRUITINGNew York, New York, 10065, United States
-
Stanford University
NOT_YET_RECRUITINGStanford, California, 94305, United States
-
University of Colorado
NOT_YET_RECRUITINGAurora, Colorado, 80203, United States
-
Washington University St. Louis
NOT_YET_RECRUITINGSt Louis, Missouri, 63130, United States
Conditions
Explore the condition pages connected to this study.